Figure S2 from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial
Year: 2023
Type: other
Abstract: Supplemental Figure 2 Progression�Free Survival by Treatment Arm for Patients with Prior Adjuvant Tamoxifen (A) Low sTKI (B) High sTKI
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361815284
